Ntv Asset Management LLC Eli Lilly & CO Transaction History

Ntv Asset Management LLC

$733 Million
Q3 2024

A detailed history of Ntv Asset Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Ntv Asset Management LLC holds 37,024 shares of LLY stock, worth $27.7 Million. This represents 4.47% of its overall portfolio holdings.

Number of Shares

37,024

Previous 37,282 0.69%

Holding current value

$27.7 Million

Previous $33.8 Million 2.82%

% of portfolio

4.47%

Previous 4.91%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	SELL	$772.14 - $960.02 $199,212 - $247,685	-258 Reduced 0.69%	37,024 $32.8 Million
Q2 2024 Jul 31, 2024	SELL	$724.87 - $909.04 $75,386 - $94,540	-104 Reduced 0.28%	37,282 $33.8 Million
Q1 2024 May 07, 2024	SELL	$592.2 - $792.28 $264,713 - $354,149	-447 Reduced 1.18%	37,386 $29.1 Million
Q4 2023 Feb 06, 2024	SELL	$525.19 - $619.13 $738,942 - $871,115	-1,407 Reduced 3.59%	37,833 $22.1 Million
Q3 2023 Nov 06, 2023	SELL	$434.7 - $599.3 $257,777 - $355,384	-593 Reduced 1.49%	39,240 $21.1 Million
Q2 2023 Aug 02, 2023	SELL	$350.74 - $468.98 $30,514 - $40,801	-87 Reduced 0.22%	39,833 $18.7 Million
Q1 2023 May 05, 2023	SELL	$310.63 - $364.82 $179,544 - $210,865	-578 Reduced 1.43%	39,920 $13.7 Million
Q4 2022 Feb 08, 2023	SELL	$321.55 - $374.67 $21,222 - $24,728	-66 Reduced 0.16%	40,498 $14.8 Million
Q3 2022 Nov 07, 2022	SELL	$296.48 - $337.87 $75,898 - $86,494	-256 Reduced 0.63%	40,564 $13.1 Million
Q2 2022 Jul 28, 2022	SELL	$278.73 - $327.27 $152,186 - $178,689	-546 Reduced 1.32%	40,820 $13.2 Million
Q1 2022 May 06, 2022	SELL	$234.69 - $291.66 $32,856 - $40,832	-140 Reduced 0.34%	41,366 $11.8 Million
Q4 2021 Feb 04, 2022	SELL	$224.85 - $279.04 $77,798 - $96,547	-346 Reduced 0.83%	41,506 $11.5 Million
Q3 2021 Nov 10, 2021	SELL	$221.6 - $272.71 $249,964 - $307,616	-1,128 Reduced 2.62%	41,852 $9.67 Million
Q2 2021 Aug 09, 2021	SELL	$180.55 - $233.54 $94,608 - $122,374	-524 Reduced 1.2%	42,980 $9.87 Million
Q1 2021 May 10, 2021	SELL	$164.32 - $212.72 $65,728 - $85,088	-400 Reduced 0.91%	43,504 $8.13 Million
Q4 2020 Feb 05, 2021	BUY	$130.46 - $172.63 $913 - $1,208	7 Added 0.02%	43,904 $7.41 Million
Q3 2020 Oct 29, 2020	SELL	$146.22 - $169.13 $13,744 - $15,898	-94 Reduced 0.21%	43,897 $6.5 Million
Q2 2020 Aug 07, 2020	BUY	$136.42 - $164.18 $38,334 - $46,134	281 Added 0.64%	43,991 $7.22 Million
Q1 2020 May 06, 2020	SELL	$119.05 - $147.35 $106,311 - $131,583	-893 Reduced 2.0%	43,710 $6.06 Million
Q4 2019 Jan 30, 2020	SELL	$106.92 - $132.43 $20,635 - $25,558	-193 Reduced 0.43%	44,603 $5.86 Million
Q3 2019 Nov 04, 2019	SELL	$106.79 - $116.16 $20,610 - $22,418	-193 Reduced 0.43%	44,796 $5.01 Million
Q2 2019 Jul 29, 2019	SELL	$110.79 - $129.32 $110,900 - $129,449	-1,001 Reduced 2.18%	44,989 $4.98 Million
Q1 2019 Apr 29, 2019	SELL	$111.31 - $131.02 $160,731 - $189,192	-1,444 Reduced 3.04%	45,990 $5.97 Million
Q4 2018 Jan 28, 2019	SELL	$105.9 - $118.64 $105,264 - $117,928	-994 Reduced 2.05%	47,434 $5.49 Million
Q3 2018 Nov 08, 2018	SELL	$85.86 - $107.31 $105,178 - $131,454	-1,225 Reduced 2.47%	48,428 $5.2 Million
Q2 2018 Aug 06, 2018	SELL	$75.7 - $86.88 $207,569 - $238,224	-2,742 Reduced 5.23%	49,653 $4.24 Million
Q1 2018 May 04, 2018	SELL	$74.21 - $87.6 $16,029 - $18,921	-216 Reduced 0.41%	52,395 $4.05 Million
Q4 2017 Feb 06, 2018	SELL	$81.94 - $87.89 $40,396 - $43,329	-493 Reduced 0.93%	52,611 $4.44 Million
Q3 2017 Nov 06, 2017	SELL	$77.07 - $85.54 $165,083 - $183,226	-2,142 Reduced 3.88%	53,104 $4.54 Million
Q2 2017 Aug 08, 2017	BUY	N/A	55,246	55,246 $4.55 Million

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ntv Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ntv Asset Management LLC with notifications on news.

Account

Ntv Asset Management LLC Eli Lilly & CO Transaction History